Skip to main content
Egyptian Rheumatology and Rehabilitation

Table 2 Distribution of the LGALS9 (genotypes and alleles) in patients with RA and healthy individuals

From: A study of the association between Galectin-9 gene (LGALS9) polymorphisms and rheumatoid arthritis in Egyptian patients

 

Control

RA

P

OR

95% CI

N = 25

N = 60

N

%

N

%

LGALS9

CC

5

20

4

6.7

–

1

(Reference)

CT

15

60

18

30

0.591 (NS)

1.289

0.510

3.257

TT

5

20

38

63.3

0.006 (S)

3.794

1.458

9.876

CT + TT

20

80

56

93.3

0.084 (NS)

2.167

0.903

5.203

C

25

50

26

21.7

–

1

(Reference)

T

25

50

94

78.3

 < 0.001 (HS)

2.185

1.425

3.351

  1. OR odds ratio, CI confidence interval, P probability, NS non-significant P (> 0.05), S significant P (≤ 0.05), HS highly significant P (< 0.001), LGALS9 Galectin-9 gene
Back to article page